Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neoplasm Metastasis × Myeloid × Clear all

Phase

Status

Sponsor Class

OTHER 10 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 278 Tumor-Agnostic 249 Thoracic 227 Breast 211 Genitourinary 181 Dermatologic 113 Head & Neck 103 Gynecologic 103 Sarcoma 63 Lymphoid 36 CNS 27 Endocrine 18 Other solid neoplasm 17 Other hematologic neoplasm 11 Plasma cell 9 NET 8 Classical hematology 3 Myeloid 1

Conditions

Myelodysplastic Syndromes 276 Leukemia, Myeloid, Acute 238 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 200 Leukemia 93 Myeloproliferative Disorders 88 Primary Myelofibrosis 82 Precursor Cell Lymphoblastic Leukemia-Lymphoma 82 Leukemia, Myelomonocytic, Chronic 68 Polycythemia Vera 61 Hematologic Neoplasms 54 Multiple Myeloma 40 Neoplasms 33 Lymphoma, Non-Hodgkin 33 Thrombocythemia, Essential 32 Hematologic Diseases 31 Leukemia, Lymphocytic, Chronic, B-Cell 30 Lymphoma 28 Recurrence 27 Leukemia, Myeloid, Chronic-Phase 26 Mastocytosis, Systemic 23 Anemia, Refractory, with Excess of Blasts 21 Leukemia, Myeloid 18 Hodgkin Disease 18 Bone Marrow Diseases 18 Blast Crisis 18 Mastocytosis 14 Philadelphia Chromosome 12 Leukemia, Mast-Cell 12 Graft vs Host Disease 12 Bronchiolitis Obliterans Syndrome 12

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06397313 2025-09-23

POTAMI-61

Ryvu Therapeutics SA

Phase 2 Recruiting

Neoplasm Metastasis, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡